IMUX
Price
$0.62
Change
-$0.02 (-3.12%)
Updated
Jan 16 closing price
Capitalization
74.34M
32 days until earnings call
Intraday BUY SELL Signals
OKYO
Price
$2.21
Change
-$0.18 (-7.53%)
Updated
Jan 16 closing price
Capitalization
83.12M
38 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IMUX vs OKYO

Header iconIMUX vs OKYO Comparison
Open Charts IMUX vs OKYOBanner chart's image
Immunic
Price$0.62
Change-$0.02 (-3.12%)
Volume$1.36M
Capitalization74.34M
OKYO Pharma
Price$2.21
Change-$0.18 (-7.53%)
Volume$184.58K
Capitalization83.12M
IMUX vs OKYO Comparison Chart in %
IMUX
Daily Signal:
Gain/Loss:
OKYO
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
IMUX vs. OKYO commentary
Jan 18, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMUX is a Hold and OKYO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 18, 2026
Stock price -- (IMUX: $0.62 vs. OKYO: $2.21)
Brand notoriety: IMUX and OKYO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMUX: 93% vs. OKYO: 109%
Market capitalization -- IMUX: $74.34M vs. OKYO: $83.12M
IMUX [@Biotechnology] is valued at $74.34M. OKYO’s [@Biotechnology] market capitalization is $83.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $111.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMUX’s FA Score shows that 0 FA rating(s) are green whileOKYO’s FA Score has 0 green FA rating(s).

  • IMUX’s FA Score: 0 green, 5 red.
  • OKYO’s FA Score: 0 green, 5 red.
According to our system of comparison, OKYO is a better buy in the long-term than IMUX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMUX’s TA Score shows that 4 TA indicator(s) are bullish while OKYO’s TA Score has 5 bullish TA indicator(s).

  • IMUX’s TA Score: 4 bullish, 5 bearish.
  • OKYO’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, OKYO is a better buy in the short-term than IMUX.

Price Growth

IMUX (@Biotechnology) experienced а -7.05% price change this week, while OKYO (@Biotechnology) price change was -19.93% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.24%. For the same industry, the average monthly price growth was +4.14%, and the average quarterly price growth was +42.40%.

Reported Earning Dates

IMUX is expected to report earnings on Feb 19, 2026.

OKYO is expected to report earnings on Feb 25, 2026.

Industries' Descriptions

@Biotechnology (+1.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OKYO($83.1M) has a higher market cap than IMUX($74.3M). IMUX YTD gains are higher at: 15.795 vs. OKYO (6.763).
IMUXOKYOIMUX / OKYO
Capitalization74.3M83.1M89%
EBITDA-105.37MN/A-
Gain YTD15.7956.763234%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash35.1MN/A-
Total Debt792KN/A-
FUNDAMENTALS RATINGS
IMUX: Fundamental Ratings
IMUX
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
15

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMUXOKYO
RSI
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
86%
Momentum
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
77%
MACD
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 6 days ago
70%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
70%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
59%
Advances
ODDS (%)
Bullish Trend 14 days ago
83%
Bullish Trend 6 days ago
87%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
IMUX
Daily Signal:
Gain/Loss:
OKYO
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HNSBF2.91N/A
N/A
Hansa Medical AB
IBIDF40.50N/A
N/A
Ibiden Co. Ltd.
OIGLF0.03N/A
N/A
Chariot Ltd.
RTBBF25.61N/A
N/A
RATHBONES GROUP PLC.
RBLK0.32N/A
N/A
Related Blocks Inc.

IMUX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMUX has been loosely correlated with PLRX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if IMUX jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMUX
1D Price
Change %
IMUX100%
-3.27%
PLRX - IMUX
36%
Loosely correlated
+0.78%
ERAS - IMUX
35%
Loosely correlated
+0.63%
ORIC - IMUX
34%
Loosely correlated
+5.21%
ENSC - IMUX
29%
Poorly correlated
-6.46%
MESO - IMUX
29%
Poorly correlated
-1.58%
More

OKYO and

Correlation & Price change

A.I.dvisor tells us that OKYO and XRTX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OKYO and XRTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OKYO
1D Price
Change %
OKYO100%
-7.53%
XRTX - OKYO
30%
Poorly correlated
-0.88%
IMUX - OKYO
28%
Poorly correlated
-3.27%
NXTC - OKYO
28%
Poorly correlated
+0.31%
DYN - OKYO
28%
Poorly correlated
+1.74%
PDSB - OKYO
27%
Poorly correlated
+0.70%
More